
BASF broadens biotech business by Isobionics acquisition
The acquisition of Isobionics BV (Geleen, The Netherlands) gives the the German world chemistry leader a foothold in the growing US$20.75bn market...

4SC expands domatinostat combo testing
In an investigator-initiated Phase Ib study (DONIMI) at NKI, 40 patients with melanoma will be enrolled before surgery (neoadjuvant setting) to...

Zealand Pharma acquires Encycle
Under the agreement, Zealand Pharma A/S will acquire all outstanding shares in Encycle Therapeutics Inc., and all its intellectual property,...

Protein protects against liver fibrosis
In mice, a team headed by Philipp Lang from University Düsseldorf, Germany, showed that the iRhom2 protein counteracted the injury- and...

GHO capital launches EU's largest fund ever for life sciences
Global Healthcare Opportunities, or GHO Capital Partners LLP said that its finally closed Fund II will be focussed on high growth healthcare...

PFF Group NV acquires stake in Autolus Therapeutics
With the investment into London-headquartered Autolus Therapeutics, PPF Group N.V. significantly increased its commitment to the healthcare sector....

EU with poor success in fighting superbugs
Although some progress has been made through EU action, there is little evidence so far to suggest that the health burden of antimicrobial resistance...